Evaluation of an inner city HIV pre-exposure prophylaxis service tailored to the needs of people who inject drugs

被引:12
|
作者
Grimshaw, Ceilidh [1 ]
Boyd, Lynsey [1 ]
Smith, Matt [2 ]
Estcourt, Claudia S. [2 ]
Metcalfe, Rebecca [1 ]
机构
[1] NHS Greater Glasgow & Clyde, Sandyford Initiat, 6 Sandyford Pl, Glasgow G3 7NB, Lanark, Scotland
[2] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland
关键词
adherence; people who inject drugs; pre-exposure prophylaxis; service; uptake; ANTIRETROVIRAL PROPHYLAXIS;
D O I
10.1111/hiv.13181
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives HIV prevention strategies including pre-exposure prophylaxis (PrEP) must reach all in need to achieve elimination of transmission by 2030. Mainstream provision may inadvertently exclude key populations. Incidence of HIV in people who inject drugs (PWID) in Glasgow, Scotland's largest city, is increasing, partly due to sexual transmission. Scotland provides publicly funded oral PrEP for individuals at sexual risk of HIV through sexual health services; however, uptake by PWID has been negligible. We developed a tailored outreach PrEP service based in the local homeless health centre. We used active case finding, flexibility of assessment location, supervised community daily dispensing and active follow-up to optimise uptake and adherence. We describe a two-year service evaluation. Methods We reviewed the case records of all PWID identified by the outreach team as being at higher risk of sexual acquisition for whom PrEP was considered between November 2018 and November 2020. Evaluation focused on PrEP uptake, adherence and monitoring. We conducted a descriptive statistical analysis. Results Of 41 PWID assessed as eligible, 32 (78.0%) commenced PrEP. The proportion of PrEP-covered days was 3320/3400 days (97.6%); 31/32 (96.9%) had regular HIV serology monitoring. The service was feasible to run, but it relied on outreach provision and liaison with other services. Discussion Tailored PrEP services can reach PWID effectively. Uptake and adherence were high but the model was resource-intensive. Appropriately tailored PrEP delivery may be required to meet the needs of this and other key populations who experience barriers to accessing mainstream services.
引用
收藏
页码:965 / 970
页数:6
相关论文
共 50 条
  • [31] High Prevalence of Indications for Pre-exposure Prophylaxis Among People Who Inject Drugs in Boston, Massachusetts
    Earlywine, Joel J.
    Bazzi, Angela R.
    Biello, Katie B.
    Klevens, R. Monina
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2021, 60 (03) : 369 - 378
  • [32] Extremely limited knowledge and moderate interest in HIV pre-exposure prophylaxis among people who inject drugs in Madrid, Spain
    Valencia, J.
    Cuevas, G.
    V. Lazarus, J.
    Vazquez Guillamet, L. J.
    Lozano, D.
    Alvarez, J.
    Gonzalez, R.
    Ryan, P.
    HIV MEDICINE, 2023, 24 : 494 - 495
  • [33] PRE-EXPOSURE PROPHYLAXIS (PREP) FOR PEOPLE WHO INJECT DRUGS: RECONCILING COMMUNITY VIEWS AND BIOMEDICAL ADVANCES
    Guise, Andy
    Albers, Eliot Ross
    Strathdee, Steffanie A.
    ADDICTION, 2017, 112 (04) : 584 - 585
  • [34] The HIV pre-exposure prophylaxis continuum of care among women who inject drugs: A systematic review
    Guy, Danielle
    Doran, Jason
    White, Trenton M.
    van Selm, Lena
    Noori, Teymur
    Lazarus, Jeffrey V.
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [35] Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC
    Kuo, Irene
    Olsen, Halli
    Patrick, Rudy
    Phillips, Gregory, II
    Magnus, Manya
    Opoku, Jenevieve
    Rawls, Anthony
    Peterson, James
    Hamilton, Flora
    Kharfen, Michael
    Greenberg, Alan
    DRUG AND ALCOHOL DEPENDENCE, 2016, 164 : 8 - 13
  • [36] Human immunodeficiency virus pre-exposure prophylaxis awareness among people who inject drugs in Portland, Oregon
    Spencer, Hunter C.
    Babiarz, Jane
    Menza, Tim W.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2023, 34 (08) : 567 - 573
  • [37] Acceptability of injectable pre-exposure prophylaxis among people who inject drugs in three urban US settings
    King, Adrian R.
    Shah, Saanchi
    Randall, Laura A.
    Frew, Paula M.
    Spaulding, Anne
    Holloway, Ian W.
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [38] An Exploration of Pre-exposure Prophylaxis (PrEP) Initiation Among Women Who Inject Drugs
    Felsher, Marisa
    Ziegler, Eliza
    Smith, Laramie R.
    Sherman, Susan G.
    Amico, K. Rivet
    Fox, Rachel
    Madden, Kayla
    Roth, Alexis M.
    ARCHIVES OF SEXUAL BEHAVIOR, 2020, 49 (06) : 2205 - 2212
  • [39] An Exploration of Pre-exposure Prophylaxis (PrEP) Initiation Among Women Who Inject Drugs
    Marisa Felsher
    Eliza Ziegler
    Laramie R. Smith
    Susan G. Sherman
    K. Rivet Amico
    Rachel Fox
    Kayla Madden
    Alexis M. Roth
    Archives of Sexual Behavior, 2020, 49 : 2205 - 2212
  • [40] Examining HIV pre-exposure prophylaxis (PrEP) acceptability among rural people who inject drugs: predictors of PrEP interest among syringe service program clients
    Surratt, Hilary L.
    Brown, Sarah
    Burton, Abby L.
    Cranford, Will
    Green, Christie
    Mersch, Stephanie M.
    Rains, Rebecca
    Westgate, Philip M.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2024, 36 (12): : 1858 - 1868